athletic training increases the red cell mass, and it seems for patients with PAVMs, they may adapt to meet oxygen demands on exercise. On cardiopulmonary exercise testing of 21 patients with PAVMs, maximal work rate and oxygen consumption (V[dot] O 2 ) were no lower in more hypoxaemic patients. 4 WY: But what if the PaO 2 /SaO 2 falls suddenly? His SaO 2 fell by 10% from lying to standing.
CLS: A fall in SaO 2 on standing (orthodeoxia) is common in patients with PAVMs: in a recent series, 75/257 (29%) consecutive patients with PAVMs demonstrated a fall in SaO 2 of at least 2% on standing. 5 Obviously, the bone marrow does not respond within minutes to hours, and there is therefore an acute fall in CaO 2 . WY: So his CaO 2 will have fallen by 2.6 mL/dLis this why his pulse rose by 49 bpm on standing?
CLS: In the 257 patients with PAVMs reported recently, an exuberant postural tachycardia did appear to be part of the compensatory mechanism to acute falls in SaO 2 /CaO 2 . 5 This evokes similarities with the tachycardic response to blood volume depletion and/or haemorrhage-similar baroreceptor mechanisms may be operating.
WY: Oxygen guidelines 6 would recommend supplementary oxygen for an SaO 2 of 78.5% at rest.
CLS: Patients with PAVMs do not fit into any of the groups considered in the normal oxygen guidelines. Oxygen supplementation is helpful in the alleviation of symptoms in hypoxaemic patients with PAVMs, for example, if they are breathless, have cardiac symptoms such as angina or palpitations, or describe neurological symptoms. It is important to remember that there is no rationale to prescribe oxygen to alleviate pulmonary hypertension because PAVMs are not associated with alveolar hypoxia, and patients are not at risk of hypoxic pulmonary hypertension. 3 4 WY: Don't the polycythaemia guidelines 7 suggest that this patient should have been venesected? CLS: Maybe, but only if you think his PAVMs meant he should be considered as having a respiratory disease, when venesection of the asymptomatic patient is recommended.
DML: There is evidence venesection may be of benefit to patients with erythrocytosis secondary to hypoxic pulmonary disease in terms of effort tolerance and neurocognitive function, which mirror improvement in pulmonary vascular resistance and cerebral blood flow. This was initially demonstrated in patients with cor pulmonale. Current guidelines 7 recommend venesection is considered if the haematocrit is >0.56 or if there are symptoms of hyperviscosity. PAVMs, however, differ from other forms of hypoxic pulmonary disease due to airflow obstruction or interstitial lung disease.
CLS: The pathology most resembling PAVMs is cyanotic congenital heart disease for which the polycythaemia guidelines 7 only recommend venesection if the patient describes symptoms of hyperviscosity. In this case, as the haematocrit was so high (0.61%), venesection was considered. However, since embolisation was scheduled to take place shortly after review, the decision was deferred until after correction of hypoxaemia. Venesection is not without risk: inducing iron deficiency by venesection is likely to be detrimental, not only in terms of increased cardiac Open Access Scan to access more free content demands to maintain tissue oxygen delivery but also because iron deficiency is now recognised to be a strong risk factor for paradoxical embolic stroke in patients with PAVMs: In a series of 497 consecutive patients with CT-proven pulmonary AVMs, the stroke risk was 4% higher for every mmol/L fall in serum iron, implying for the same PAVM(s) the stroke risk would approximately double with serum iron 6 mmol/L compared with mid-normal range (7-27 mmol/L).
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WY: And stroke prevention was why treatment of this patient's PAVMs was recommended. He underwent a series of embolisation treatments.
JEJ: All three of this young man's PAVMs had a complex angiographic anatomy; in other words, each consisted of numerous arteriovenous communications arising from multiple adjacent peripheral pulmonary arterial branches. This is opposed to the more common 'simple' anatomy where there is a single feeding vessel communicating directly with a venous sac. The successful embolisation of complex lesions is difficult and, in this case, required three separate procedures in order to occlude the majority of the abnormal arteriovenous communications using a combination of Amplatzer vascular plugs and MR-compatible metallic coils ( figure 1A, B) . WY: Four years later, the SaO 2 was 95% on air ( figure 1C) . He was about to resume football (which he had stopped playing for social reasons), but did state "I don't feel any different -but then I felt completely fine before." Why did he feel no better when his SaO 2 was now almost normal?
CLS: You can work this out. What was his haemoglobin on follow-up?
WY: The haemoglobin had fallen to 15.6 g/dL with normochromic normocytic indices and no evidence of iron deficiency.
CLS: The fall in haemoglobin means that the CaO 2 was no higher than at presentation, despite the increased SaO 2 . Across 71 patients with PAVMs, haemoglobin fell after embolisation such that several months after embolisation the CaO 2 was no higher despite higher SaO 2 .
3 At 20 mL/dL, his CaO 2 was in fact a little lower than at presentation, potentially reflecting his reduced sporting training. There are no cardiopulmonary exercise data for him, but data are reported on five other patients with PAVMs, exercised before and several months after embolisation that increased SaO 2 from 88-94% to 94-96% ( p=0.009): there was no difference in perceived dyspnoea, maximum workload or maximal oxygen consumption (V[dot] O 2 ) after embolisation. So patients with PAVMs use compensatory processes to preserve oxygen delivery to the tissues, even on exercise, and reset these after correction of hypoxaemia. 3 4 9 WY: Does everyone with PAVM-induced hypoxaemia manage this well?
CLS: No, not everyone. Concurrent diseases interfere with the ability to compensate. The most common problems we see are iron deficiency (leading to a spectrum that ranges from anaemia to 'just' impaired polycythaemia/inappropriately normal haemoglobin 2 ) and/or concurrent cardiorespiratory disease. Patients with PAVMs and these additional problems tend to report more dyspnoea, are less able to exercise and are more likely to report improvements after embolisation. 2 Their symptoms are remarkably similar to those of pure anaemia, which effectively results in the same problem-it is harder work to deliver oxygen to the tissues.
In summary, this case illustrates how successfully haematological and cardiovascular compensations can maintain oxygen delivery to the tissues in hypoxaemic patients with PAVMs. Do not forget, however, that patients with PAVMs are unusual in their ability to compensate for hypoxaemia: the PAVM results on tolerance of hypoxemia 3 4 should not be extrapolated to other hypoxaemic patients, where more usual oxygen guidance as used in acute and respiratory medicine applies.
